company
Daavlin Distributing Company
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · device_recall2026-06-10Daavlin Distributing Company — Class II recall: Phothera 200, Phototherapy Devices indicated for use to treat diagnosed skin dis…
Frequently asked questions
- How many FDA warning letters has Daavlin Distributing Company received?
- Argus HQ has not recorded an FDA warning letter for Daavlin Distributing Company in our current dataset.
- What FDA recalls has Daavlin Distributing Company issued?
- Argus HQ has recorded 1 FDA recall tied to Daavlin Distributing Company.
- Is Daavlin Distributing Company FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 1 recall, and 0 approval records for Daavlin Distributing Company. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

